Barclays initiated coverage of Aspen Aerogels with an Overweight rating and $27 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- ASPN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Aspen Aerogels management to meet virtually with Seaport Research
- Aspen Aerogels price target raised to $38 from $33 at Craig-Hallum
- Aspen Aerogels price target raised to $38 from $31 at Seaport Research
- Aspen Aerogels Confirms Financial Outlook for 2024